Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD [Yahoo! Finance]
Simulations Plus, Inc. (SLP)
Last simulations plus, inc. earnings: 4/9 04:35 pm
Check Earnings Report
US:NASDAQ Investor Relations:
simulations-plus.com/software/overview
Company Research
Source: Yahoo! Finance
RESEARCH TRIANGLE PARK, N.C., March 03, 2026 BUSINESS WIRE )--Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced a high-impact panel discussion, "From Debate to Deployment: Responsible, Practical AI in MIDD," to be held during the upcoming American Society for Clinical Pharmacology & Therapeutics (ASCPT) Annual Meeting on March 5, 2026 at 12:00 PM MST in Denver, CO. "There is no longer a question of whether artificial intelligence (AI) should be used in drug development, but how to implement it responsibly, defensibly, and with measurable value," said Dr. Viera Lukacova, Chief Scientific Officer of Simulations Plus and moderator of the panel. "We are excited to bring together leaders who can share perspectives influenced by their industry and regulatory experiences to discuss the cost and impact that should be considered by scientists, s
Show less
Read more
Impact Snapshot
Event Time:
SLP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLP alerts
High impacting Simulations Plus, Inc. news events
Weekly update
A roundup of the hottest topics
SLP
News
- Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug ProductsBusiness Wire
- Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring SchoolBusiness Wire
- Here's Simulations Plus Inc (SLP)'s Vision for AI in Drug Development [Yahoo! Finance]Yahoo! Finance
- Simulations Plus: Better Quarter, Same Doubts [Seeking Alpha]Seeking Alpha
- Simulations Plus (SLP) had its price target lowered by TD Cowen from $19.00 to $16.00. They now have a "hold" rating on the stock.MarketBeat
SLP
Earnings
- 4/9/26 - Beat
SLP
Sec Filings
- 4/16/26 - Form 4
- 4/15/26 - Form 144
- 4/10/26 - Form 10-Q
- SLP's page on the SEC website